Menotrophin

Menotrophin, the active ingredient in Menotrophin, is a Gonadotropin (FSH/LH) preparation presented as a solution for injection for subcutaneous use. It treats infertility caused by anovulation, supports assisted reproductive technology cycles, and manages hypogonadotropic hypogonadism by providing exogenous FSH and LH activity.

GNH USA supplies Menotrophin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable cold‑chain logistics for biologic products, ensuring product integrity from manufacturing to end‑user.

Menotrophin is used in reproductive endocrinology to stimulate ovarian follicular development and ovulation.

Infertility due to anovulation: stimulates follicular growth to enable ovulation. Assisted reproductive technology (e.g., IVF): provides controlled ovarian stimulation for egg retrieval. Hypogonadotropic hypogonadism: replaces deficient gonadotropins to restore normal reproductive hormone axis.

Menotrophin may be associated with a range of adverse reactions, most of which are related to its hormonal activity and injection route.

Common Side Effects: - Injection site pain or erythema - Mild ovarian hyperstimulation syndrome (abdominal bloating, discomfort) - Headache - Nausea - Fatigue

Serious or Rare Side Effects: - Severe ovarian hyperstimulation syndrome (rapid weight gain, shortness of breath) - Thromboembolic events (deep vein thrombosis, pulmonary embolism) - Allergic reactions including anaphylaxis

When prescribing Menotrophin, clinicians should observe several precautionary measures to minimise risks.

Patient selection: assess for ovarian cysts or estrogen‑dependent tumors. Monitoring: perform ultrasound and estradiol level checks during stimulation. Contraindications: avoid in uncontrolled thyroid disease or pituitary tumors. Pregnancy: discontinue once pregnancy is confirmed. Drug interactions: review concomitant hormonal therapies. Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Menotrophin can interact with other agents that affect hormonal balance or coagulation.

Major Interactions (Avoid): - GnRH agonists: may amplify ovarian response leading to severe OHSS. - Estrogen‑containing oral contraceptives: can blunt stimulation effect. - Anticoagulants: increased risk of thromboembolic complications with OHSS.

Moderate Interactions (Monitor Closely): - Thyroid hormone replacement: adjust dosing based on hormone levels. - Corticosteroids: may affect follicular response. - Insulin sensitizers (e.g., metformin): monitor glucose and ovarian response.